Source:http://linkedlifedata.com/resource/pubmed/id/19387682
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-6-9
|
pubmed:abstractText |
In the present study we investigated the protein expression of claudins 1, 3, and 4 and their relationship to clinical variables and outcome in a cohort of ER-ve and ER+ve human invasive breast cancers. Immunohistochemical analysis was performed on tissue microarrays representing a total of 412 tumors and interpretable data was derived from 314, 299, and 306 tumors for claudins 1, 3, and 4, respectively. In the ER+ve subset, 5%, 89%, and 52%, and in the ER-ve subset, 39%, 79%, and 79% of tumors stained positively for claudins 1, 3, and 4, respectively (p < 0.0001, p = 0.026, p < 0.0001). Thus, in the two subsets, a significantly higher number of tumors were positive for claudins 3 and 4, compared to claudin 1. In addition, protein expressions of claudins 1 and 4 were significantly higher in those tumors that displayed characteristics of the basal-like subtype of breast cancers (ER-ve, Her-2-ve, EGFR+ve, CK5/6+ve). This study shows a unique pattern of expression for the different claudins in ER-ve and ER+ve tumors. Our data also suggests that increased expression of claudins 1 and 4 was associated with the basal-like subtype of breast cancers, a subtype generally linked to poor outcome.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/claudin 1,
http://linkedlifedata.com/resource/pubmed/chemical/claudin 3,
http://linkedlifedata.com/resource/pubmed/chemical/claudin 4
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1432-2307
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
454
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
647-56
|
pubmed:dateRevised |
2009-8-20
|
pubmed:meshHeading |
pubmed-meshheading:19387682-Breast Neoplasms,
pubmed-meshheading:19387682-Female,
pubmed-meshheading:19387682-Humans,
pubmed-meshheading:19387682-Membrane Proteins,
pubmed-meshheading:19387682-Neoplasm Invasiveness,
pubmed-meshheading:19387682-Receptors, Estrogen,
pubmed-meshheading:19387682-Tissue Array Analysis,
pubmed-meshheading:19387682-Tumor Markers, Biological
|
pubmed:year |
2009
|
pubmed:articleTitle |
Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype.
|
pubmed:affiliation |
Department of Pathology, University of Manitoba, 770 Bannatyne Avenue, Winnipeg, Manitoba, Canada R3E0W3. ablanch@cc.umanitoba.ca
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|